LP
FOMX

LMR Partners’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

LMR Partners’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-17,600
Closed -$112K – 540
2016
Q2 		$112K Buy
+17,600
New +$117K 0.02% 392

Other funds holding FOMX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

LMR Partners's FOMX Position: Q3 2016 in Review

LMR Partners sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q3 2016, closing a stake of 17,600 shares — an estimated $112K sold.

LMR Partners first reported a position in FOMX in Q2 2016 and held it in 1 quarter. The position peaked at $112K in Q2 2016. 61 funds tracked by Wall St. Rank hold FOMX as of Q3 2016.

  • LMR Partners reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q3 2016 after selling out during the quarter.
  • LMR Partners sold 17,600 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q3 2016, an estimated $112K.
  • LMR Partners first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2016 and held it in 1 quarter.
  • LMR Partners's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $112K in Q2 2016.
  • 61 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q3 2016.

Based on LMR Partners's 13F filing for Q3 2016, filed 1 Nov 2016.